Comparative Study of Different Smoking Cessation Interventions on Lung Health Outcomes in Patients with COPD

Authors

  • Ghazala Yasmeen Department of Community Medicine, Sheikh Zayed Medical College, Rahim Yar Khan - Pakistan
  • Bilal Ahmad Rehmani Department of Primary and Secondary Healthcare, Tehsil Headquarters Hospital, Liaquatpur - Pakistan
  • Syed Tabish Rehman Department of Chest Medicine, Liaquat National Hospital, Karachi - Pakistan
  • Hafiz Umer Farooq Department of Community Medicine, Sheikh Zayed Medical College, Rahim Yar Khan - Pakistan
  • Tahir Mukhtar Sayed Department of Medicine, Akhtar Saeed Medical College, Rawalpindi - Pakistan
  • Muhammad Ikram Ul Haq Department of Medicine, Niazi Medical and Dental College, Sargodha - Pakistan

Keywords:

Respiratory Diseases, Chronic obstructive airway disease (COPD), Smoking Cessation

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a major global health issue, with cigarette smoking as a leading risk factor.Objective: This systematic review evaluates the effectiveness of various smoking cessation interventions in improving lung health in COPD patients.Methodology: A comprehensive search of databases, including PubMed, Embase, and Cochrane Library, was conducted using keywords such as "COPD," "smoking cessation," "nicotine replacement therapy," and "varenicline." The review included randomized controlled trials (RCTs) that assessed lung function outcomes, focusing on forced expiratory volume (FEVâ‚) and exacerbation rates. Results: Out of 1,200 initially identified studies, 12 RCTs met the inclusion criteria. The data indicated that combined pharmacological treatments (particularly varenicline) and behavioral therapies were most effective in promoting smoking cessation and enhancing lung function. The combination of these approaches led to improved FEVâ‚ and reduced COPD exacerbations. Conclusion: Smoking cessation interventions, particularly those integrating pharmacotherapy with behavioral support, significantly improve lung health and quality of life in COPD patients. Individualized cessation programs are recommended to optimize patient outcomes, though further studies are needed to assess long-term effectiveness and generalizability across broader patient populations.

References

World Health Organization. Chronic obstructive pulmonary disease (COPD). 2022. Available from URL: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)

Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2023). Global strategy for the diagnosis, management, and prevention of COPD. GOLD. 2023. Available form URL: https://goldcopd.org/.

Tashkin DP, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med. 2009;103(7):963-74. DOI:10.1016/j.rmed.2009.02.013

Anthonisen NR, Connett JE, Kiley JP. (2005). Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEVâ‚. J Ameri Med Assoc. 2005;272(19):1497-1505. DOI:10.1001/jama.1994.03520190037038.

Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clin Pract Guidel. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008.

Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network metaâ€analysis. Cochrane Database Syst Rev. 2013;(5). DOI:10.1002/14651858.CD009329.pub2.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;(11). DOI:10.1002/14651858.CD000146.pub4.

Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S. A double-blind trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 2006;345(5):311-317. DOI:10.1056/NEJM200108023450504.

Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med. 2005;165(19):2286-2292. DOI:10.1001/archinte.165.19.2286.

Borglykke A, Pisinger C, Jørgensen T, Ibsen H, Møller J, Sørensen J, et al. The effectiveness of group-based counseling and individual counseling for smoking cessation: a comparative analysis. Addict Res Theory. 2019;12(6):533-540. DOI:10.1080/16066359.2019.1234672.

Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med. 2000;161(2):381-390. DOI:10.1164/ajrccm.161.2.9901037.

Tashkin DP, Kanner RE, Bailey W, Dolganov G, Senn S, Karpel J, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled multicenter randomized trial. Lancet. 2001;357(9268):1571-1575. DOI:10.1016/S0140-6736(00)04721-7.

Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest. 2006;130(2):332-342. DOI: 10.1378/chest.130.2.332.

Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233-239.

Tashkin DP, Celli B, Senn S, McElvaney NG, McMahon D, McCarthy K, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543-1554. DOI:10.1056/NEJMoa0805800.

Fiore MC, Bailey WC, Cohen SJ, Treat J, Cokkinides V, Wewers ME, et al. Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA. 1996;275(16):1270-1280. DOI:10.1001/jama.1996.03530400058039.

Jansson-Fröjmark M, Lundqvist D, Lundqvist N, Linton SJ, Järvholm L, Möller J, et al. Psychosocial work stressors for insomnia: a prospective study on 50–60-year-old adults in the working population. Int J Behav Med. 2007;14:222-228.

Kanner RE, Connett JE, Williams DE, Lindgren P, Celli BR, Rennard SI, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease. Am J Med. 1999;106(5):675-679. DOI: 10.1016/S0002-9343(99)00136-0.

Bohadana A, Rokach A, Wild P, Peker B, Dror YF, Babai P, et al. Varenicline for gradual versus abrupt smoking cessation in poorly motivated smokers with COPD: A prematurely terminated randomized controlled trial. Chronic Obstr Pulm Dis. 2022. DOI: 10.15326/jcopdf.2022.0305.

Ellerbeck EF, Nollen N, Hutcheson TD, Phadnis M, Fitzgerald SA, Vacek J, et al. Effect of long-term nicotine replacement therapy vs standard smoking cessation for smokers with chronic lung disease. JAMA Netw Open. 2018;1(5). DOI: 10.1001/jamanetworkopen.2018.1843.

Downloads

Published

2023-03-02

How to Cite

Yasmeen, G. ., Rehmani, B. A. ., Rehman, S. T. ., Farooq, H. U. ., Sayed, T. M. ., & Haq, M. I. U. (2023). Comparative Study of Different Smoking Cessation Interventions on Lung Health Outcomes in Patients with COPD. Pakistan Journal of Chest Medicine, 29(1), 104–114. Retrieved from https://www.pjcm.net/index.php/pjcm/article/view/895

Issue

Vol. 29 No. 1 (2023)

Section

Review Article

License

Copyright (c) 2023 Pakistan Journal of Chest Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)